Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Mesalamine
Medication labelMesalamine delayed-release tablets are indicated for the: induction and maintenance of remission in adult patients with mildly to moderately…
Why this: Advisory · dailymed-prescription
Mesalamine delayed-release tablets are indicated for the: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.
- generic_name
- mesalamine
- product_names
- Mesalamine
- ndc
- 63304-175, 63304-175-13
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en